KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

AbbVie (ABBV) Leases (2019 - 2024)

Historic Leases for AbbVie (ABBV) over the last 6 years, with Q4 2024 value amounting to $723.0 million.

  • AbbVie's Leases fell 282.26% to $723.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $723.0 million, marking a year-over-year decrease of 282.26%. This contributed to the annual value of $723.0 million for FY2024, which is 282.26% down from last year.
  • AbbVie's Leases amounted to $723.0 million in Q4 2024, which was down 282.26% from $744.0 million recorded in Q4 2023.
  • In the past 5 years, AbbVie's Leases ranged from a high of $895.0 million in Q4 2020 and a low of $723.0 million during Q4 2024
  • Moreover, its 5-year median value for Leases was $744.0 million (2023), whereas its average is $772.2 million.
  • Per our database at Business Quant, AbbVie's Leases soared by 16017.44% in 2020 and then tumbled by 1486.03% in 2021.
  • AbbVie's Leases (Quarter) stood at $895.0 million in 2020, then decreased by 14.86% to $762.0 million in 2021, then fell by 3.28% to $737.0 million in 2022, then rose by 0.95% to $744.0 million in 2023, then fell by 2.82% to $723.0 million in 2024.
  • Its Leases stands at $723.0 million for Q4 2024, versus $744.0 million for Q4 2023 and $737.0 million for Q4 2022.